What is it about?
Researchers look for biological markers of depression, such as inflammation in the blood, hoping to find subgroups of patients who might benefit from specific treatments. But a marker measured in the blood does not necessarily reflect what happens in the brain. To study this gap, researchers need to know where each marker was measured: blood, saliva or the fluid around the brain and spinal cord. We examined 1166 recent PubMed articles on depression biomarkers (2024–2026) and checked whether the official indexing system used by PubMed (MeSH) records this information. In most cases it does not, and for some key markers, including C-reactive protein, the system does not allow the blood compartment to be recorded at all.
Featured Image
Photo by Vitaly Gariev on Unsplash
Why is it important?
This is the first study to show that the problem is built into the indexing system itself, not just a matter of careless indexing. About one article in five was never indexed at all, and for an entire class of blood proteins the information cannot be entered even in principle. As a result, studies on inflammation in depression cannot be reliably found, compared or pooled according to where the marker was measured. This matters most for difficult-to-treat depression, where anti-inflammatory treatments are being tested on the assumption that a blood test reflects inflammation in the brain. For clinicians, the message is to check the sample type in the Methods of each study; for researchers, to state it explicitly in the abstract; for journals and indexers, to capture it in a structured field at submission.
Perspectives
This work grew out of my clinical and research interest in difficult-to-treat depression and its possible inflammatory subtype. While searching the literature on blood markers, I realised I could not retrieve studies according to the one variable that matters most: whether the marker was measured in the blood or in the cerebrospinal fluid. What began as a practical frustration became a research question about the infrastructure we all rely on. I hope it encourages authors, journals and indexers to make the sample type visible in the record, so that the question "does a blood marker tell us anything about the brain?" can finally be asked of the whole literature.
PhD in Neuroscience Walter Paganin
StudioPsicologiaSignorini
Read the Original
This page is a summary of: What the Controlled-Vocabulary Layer Cannot Say About Where a Depression Biomarker Was Measured: A Meta Research Analysis of MeSH Sampling-Compartment Coding, January 2024–June 2026, Actas Españolas de Psiquiatría, October 2026, Juan José López-Ibor Foundation,
DOI: 10.62641/aep.2463.
You can read the full text:
Contributors
The following have contributed to this page
